Trial Profile
A Clinical Research on the Safety/Efficacy of Umbilical Cord Mesenchymal Stem Cells Therapy for Patients With Spinocerebellar Ataxia
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Apr 2024
Price :
$35
*
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy Sclnow Biotechnology (Primary) ; Umbilical cord mesenchymal stem cell therapy Sclnow Biotechnology (Primary)
- Indications Spinocerebellar ataxias
- Focus Therapeutic Use
- Sponsors Sclnow Biotechnology
- 18 Apr 2024 Planned End Date changed from 1 Dec 2024 to 31 Dec 2025.
- 18 Apr 2024 Planned primary completion date changed from 1 Jun 2024 to 30 Jun 2025.
- 18 Apr 2024 Planned initiation date changed from 1 Dec 2023 to 31 Dec 2024.